| Product NDC: | 0009-3073 |
| Proprietary Name: | Depo-Medrol |
| Non Proprietary Name: | METHYLPREDNISOLONE ACETATE |
| Active Ingredient(s): | 40 mg/mL & nbsp; METHYLPREDNISOLONE ACETATE |
| Administration Route(s): | INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; SOFT TISSUE |
| Dosage Form(s): | INJECTION, SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0009-3073 |
| Labeler Name: | Pharmacia and Upjohn Company |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA011757 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19590528 |
| Package NDC: | 0009-3073-23 |
| Package Description: | 25 VIAL, SINGLE-DOSE in 1 PACKAGE (0009-3073-23) > 1 mL in 1 VIAL, SINGLE-DOSE |
| NDC Code | 0009-3073-23 |
| Proprietary Name | Depo-Medrol |
| Package Description | 25 VIAL, SINGLE-DOSE in 1 PACKAGE (0009-3073-23) > 1 mL in 1 VIAL, SINGLE-DOSE |
| Product NDC | 0009-3073 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | METHYLPREDNISOLONE ACETATE |
| Dosage Form Name | INJECTION, SUSPENSION |
| Route Name | INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; SOFT TISSUE |
| Start Marketing Date | 19590528 |
| Marketing Category Name | NDA |
| Labeler Name | Pharmacia and Upjohn Company |
| Substance Name | METHYLPREDNISOLONE ACETATE |
| Strength Number | 40 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |